Investor Presentation BALAXI PHARMACEUTICALS LIMITED has informed the Exchange about Investor Presentation BALAXI PHARMACEUTICALS LIMITED has informed the Exchange about Investor Presentation
Investor Presentation BALAXI PHARMACEUTICALS LIMITED has informed the Exchange about Investor Presentation BALAXI PHARMACEUTICALS LIMITED has informed the Exchange about Investor Presentation
Board Meeting Pursuant to Regulation 33 of SEBI(Listing Obligations and Disclosure Requirements) Regulations, 2015, we submit herewith Audited Financial Results for the 4th Quarter and year ended 31.03.2026 along with the Report of Auditors and declaration of unmodified opinion of Statutory Auditors by the Board of Directors. Pursuant to Regulation 33 of SEBI(Listing Obligations and Disclosure Requirements) Regulations, 2015, we submit herewith Audited Financial Results for the 4th Quarter an
Board Meeting Pursuant to Regulation 33 of SEBI(Listing Obligations and Disclosure Requirements) Regulations, 2015, we submit herewith Audited Financial Results for the 4th Quarter and year ended 31.03.2026 along with the Report of Auditors and declaration of unmodified opinion of Statutory Auditors by the Board of Directors. Pursuant to Regulation 33 of SEBI(Listing Obligations and Disclosure Requirements) Regulations, 2015, we submit herewith Audited Financial Results for the 4th Quarter an
Company Update The Board of Directors in their meeting held on May 29, 2026 had considered and approved investment by way of subscription to the equity shares of "Talbros Nextgen Private Limited", a company duly incorporated as wholly owned subsidiary of the company. The Board of Directors in their meeting held on May 29, 2026 had considered and approved investment by way of subscription to the equity shares of "Talbros Nextgen Private Limited", a company duly incorporated as wholly owned subs
Company Update The Board of Directors in their meeting held on May 29, 2026 had considered and approved investment by way of subscription to the equity shares of "Talbros Nextgen Private Limited", a company duly incorporated as wholly owned subsidiary of the company. The Board of Directors in their meeting held on May 29, 2026 had considered and approved investment by way of subscription to the equity shares of "Talbros Nextgen Private Limited", a company duly incorporated as wholly owned subs
Company Update Update on intimation of fine Update on intimation of fine
Company Update Update on intimation of fine Update on intimation of fine
Board Meeting Andhra Cements Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 05/06/2026 ,inter alia, to consider and approve Board Meeting to be held on 5th June, 2026 to consider and apporve the Amalgamation Andhra Cements Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 05/06/2026 ,inter alia, to consider and approve Board Meeting to be held on 5th June, 2026 to consider and apporve the Amalgamation
Board Meeting Andhra Cements Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 05/06/2026 ,inter alia, to consider and approve Board Meeting to be held on 5th June, 2026 to consider and apporve the Amalgamation Andhra Cements Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 05/06/2026 ,inter alia, to consider and approve Board Meeting to be held on 5th June, 2026 to consider and apporve the Amalgamation
Corp. Action Recommendation of Final dividend Rs. 1/- per equity Share pf face value of Rs. 10/- each for the financial year ended 31st March 2026, subject to the approval of shareholders at the ensuring Annual General Meeting. Recommendation of Final dividend Rs. 1/- per equity Share pf face value of Rs. 10/- each for the financial year ended 31st March 2026, subject to the approval of shareholders at the ensuring Annual General Meeting.
Corp. Action Recommendation of Final dividend Rs. 1/- per equity Share pf face value of Rs. 10/- each for the financial year ended 31st March 2026, subject to the approval of shareholders at the ensuring Annual General Meeting. Recommendation of Final dividend Rs. 1/- per equity Share pf face value of Rs. 10/- each for the financial year ended 31st March 2026, subject to the approval of shareholders at the ensuring Annual General Meeting.
Quick Notification
Smart analysis of market trends
Notifications on crucial events
Alerts in the chat you already use
NSE & BSE filings, earnings, insider trades, and smart volume alerts — on WhatsApp or Telegram. No separate app to install.
"ZTOX has transformed how I track companies. The real-time alerts and AI insights save me hours of research every day."
— Aditya M., Active Trader